世界のインスリン市場2023年~2027年

【英語タイトル】Global Insulin Market 2023-2027

Technavioが出版した調査資料(IRTNTR74807-23)・商品コード:IRTNTR74807-23
・発行会社(調査会社):Technavio
・発行日:2022年12月30日
・ページ数:154
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:グローバル
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥380,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥608,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

Technavio社は、世界のインスリン市場規模が2022年から2027年まで年平均1.77%成長し、1662.41百万ドルに達すると予測しています。本調査レポートでは、インスリンの世界市場について広く調査・分析を行い、エグゼクティブサマリー、市場状況、市場規模、過去の市場規模、ファイブフォース分析、種類別(インスリンアナログ、ヒトインスリン)分析、販売チャネル別(小売薬局、病院、オンライン薬局)分析、顧客状況、地域別状況(北米、ヨーロッパ、アジア太平洋、アメリカ、イギリス、ドイツ、中国、日本、その他地域)分析、推進要因・課題・動向、企業状況、企業分析などの項目を掲載しています。なお、本書には、AdvaCare Pharma、ASP Healthcare Pty Ltd.、B. Braun SE、Becton Dickinson and Co.、Biocon Ltd.、Cardinal Health Inc.、CODAN Medizinische Gerate GmbH and Co KG、Eli Lilly and Co.、Gerresheimer AG、Gulf Pharmaceutical Industries、Healthwarehouse.com Inc.、Hindustan Syringes and Medical Devices Ltd.、Hi Tech Medics Pvt Ltd.などの企業情報が含まれています。
・エグゼクティブサマリー
・市場状況
・市場規模
・過去の市場規模
・ファイブフォース分析

・世界のインスリン市場規模:種類別
- インスリンアナログの市場規模
- ヒトインスリンの市場規模

・世界のインスリン市場規模:販売チャネル別
- 小売薬局の市場規模
- 病院の市場規模
- オンライン薬局の市場規模

・顧客状況

・地域別状況
- 北米のインスリン市場規模
- ヨーロッパのインスリン市場規模
- アジア太平洋のインスリン市場規模
- アメリカのインスリン市場規模
- イギリスのインスリン市場規模
- ドイツのインスリン市場規模
- 中国のインスリン市場規模
- 日本のインスリン市場規模
- その他地域のインスリン市場規模

・推進要因・課題・動向
・企業状況
・企業分析

Technavio社は、利益、価格、競争、プロモーションなどの主要なパラメーターを分析することにより、また複数のソースからのデータを調査、統合、および合計することにより、市場の詳細な全体像を提示します。主要産業のインフルエンサーを特定することにより、さまざまな市場の側面を提示します。提示されたデータは包括的​​で信頼性が高く、一次および二次の広範な調査の結果です。Technavio社の市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用し、完全な競争状況と詳細なベンダー選択方法と分析を提供します。

インスリンの世界市場 2023-2027

Technavio社は、インスリン市場をモニターしており、2022年から2027年にかけて1,662.41百万ドルの成長が予測され、予測期間中のCAGRは1.77%で加速すると予測しています。当レポートでは、インスリン市場について、市場規模や予測、動向、成長促進要因、課題などの全体的な分析に加え、約25のベンダーを網羅したベンダー分析も掲載しています。

当レポートでは、現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、糖尿病の有病率の増加、糖尿病につながる危険因子への曝露の増加、有利な政府のイニシアチブによって牽引されています。

Technavioのインスリン市場は以下のようにセグメント化されています:

・タイプ別:
– インスリンアナログ
– ヒトインスリン

・流通チャネル別:
– 小売薬局
– 病院
– オンライン薬局

・地域別:
– 北米
– ヨーロッパ
– アジア
– その他の地域(ROW)

本調査では、インスリン送達システムの進歩が、今後数年間のインスリン市場の成長を促進する主要な理由の1つであると特定しています。また、在宅療養環境への注目の高まり、糖尿病に対する意識の高まりや成長への取り組みが、市場の大きな需要につながるとしています。

Technavio社は、複数の情報源からのデータを調査、統合、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。

当レポートでは、インスリン市場について以下の分野をカバーしています:
– インスリン市場のサイジング
– インスリン市場予測
– インスリン市場の産業分析

Technavio社の確実なベンダー分析は、クライアントが市場でのポジションを向上できるように設計されており、これに沿って本レポートには、AdvaCare Pharma, ASP Healthcare Pty Ltd., B. Braun SE, Becton Dickinson and Co., Biocon Ltd., Cardinal Health Inc., CODAN Medizinische Gerate GmbH and Co KG, Eli Lilly and Co., Gerresheimer AG, Gulf Pharmaceutical Industries, Healthwarehouse.com Inc., Hindustan Syringes and Medical Devices Ltd., Hi Tech Medics Pvt Ltd., Mayo Foundation for Medical Education and Research, Novo Nordisk AS, Pfizer Inc., Sanofi SA, UltiMed Inc., Wockhardt Ltd., and Nipro Corpなどの企業情報が含まれています。また、インスリン市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートでは、主要ベンダーの分析に加え、包括的な市場およびベンダーの状況を掲載しています。

Technavio社は、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で市場の詳細な姿を提示します。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Distribution Channel
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global insulin market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on Global insulin market 2017 – 2021 ($ million)
o 4.2 Type Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Type Segment 2017 – 2021 ($ million)
o 4.3 Distibution channel Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Distibution channel Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Type
o 6.1 Market segments
o Exhibit 30: Chart on Type – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Type – Market share 2022-2027 (%)
o 6.2 Comparison by Type
o Exhibit 32: Chart on Comparison by Type
o Exhibit 33: Data Table on Comparison by Type
o 6.3 Insulin analog – Market size and forecast 2022-2027
o Exhibit 34: Chart on Insulin analog – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Insulin analog – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Insulin analog – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Insulin analog – Year-over-year growth 2022-2027 (%)
o 6.4 Human insulin – Market size and forecast 2022-2027
o Exhibit 38: Chart on Human insulin – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Human insulin – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Human insulin – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Human insulin – Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Type
o Exhibit 42: Market opportunity by Type ($ million)
• 7 Market Segmentation by Distribution Channel
o 7.1 Market segments
o Exhibit 43: Chart on Distribution Channel – Market share 2022-2027 (%)
o Exhibit 44: Data Table on Distribution Channel – Market share 2022-2027 (%)
o 7.2 Comparison by Distribution Channel
o Exhibit 45: Chart on Comparison by Distribution Channel
o Exhibit 46: Data Table on Comparison by Distribution Channel
o 7.3 Retail pharmacies – Market size and forecast 2022-2027
o Exhibit 47: Chart on Retail pharmacies – Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Data Table on Retail pharmacies – Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Chart on Retail pharmacies – Year-over-year growth 2022-2027 (%)
o Exhibit 50: Data Table on Retail pharmacies – Year-over-year growth 2022-2027 (%)
o 7.4 Hospitals – Market size and forecast 2022-2027
o Exhibit 51: Chart on Hospitals – Market size and forecast 2022-2027 ($ million)
o Exhibit 52: Data Table on Hospitals – Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Chart on Hospitals – Year-over-year growth 2022-2027 (%)
o Exhibit 54: Data Table on Hospitals – Year-over-year growth 2022-2027 (%)
o 7.5 Online pharmacies – Market size and forecast 2022-2027
o Exhibit 55: Chart on Online pharmacies – Market size and forecast 2022-2027 ($ million)
o Exhibit 56: Data Table on Online pharmacies – Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Chart on Online pharmacies – Year-over-year growth 2022-2027 (%)
o Exhibit 58: Data Table on Online pharmacies – Year-over-year growth 2022-2027 (%)
o 7.6 Market opportunity by Distribution Channel
o Exhibit 59: Market opportunity by Distribution Channel ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 61: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 62: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 63: Chart on Geographic comparison
o Exhibit 64: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 65: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 66: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 67: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 68: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 69: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 70: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 71: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 72: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 73: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 74: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 75: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 76: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 77: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 78: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 79: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 81: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 82: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 83: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 UK – Market size and forecast 2022-2027
o Exhibit 85: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 86: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 87: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.9 Germany – Market size and forecast 2022-2027
o Exhibit 89: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 90: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 91: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.10 China – Market size and forecast 2022-2027
o Exhibit 93: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 94: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 95: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.11 Japan – Market size and forecast 2022-2027
o Exhibit 97: Chart on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 98: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 99: Chart on Japan – Year-over-year growth 2022-2027 (%)
o Exhibit 100: Data Table on Japan – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 101: Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 102: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 103: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 104: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 105: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 106: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 107: Matrix on vendor position and classification
o 12.3 B. Braun SE
o Exhibit 108: B. Braun SE – Overview
o Exhibit 109: B. Braun SE – Business segments
o Exhibit 110: B. Braun SE – Key news
o Exhibit 111: B. Braun SE – Key offerings
o Exhibit 112: B. Braun SE – Segment focus
o 12.4 Becton Dickinson and Co.
o Exhibit 113: Becton Dickinson and Co. – Overview
o Exhibit 114: Becton Dickinson and Co. – Business segments
o Exhibit 115: Becton Dickinson and Co. – Key news
o Exhibit 116: Becton Dickinson and Co. – Key offerings
o Exhibit 117: Becton Dickinson and Co. – Segment focus
o 12.5 Biocon Ltd.
o Exhibit 118: Biocon Ltd. – Overview
o Exhibit 119: Biocon Ltd. – Business segments
o Exhibit 120: Biocon Ltd. – Key offerings
o Exhibit 121: Biocon Ltd. – Segment focus
o 12.6 Cardinal Health Inc.
o Exhibit 122: Cardinal Health Inc. – Overview
o Exhibit 123: Cardinal Health Inc. – Business segments
o Exhibit 124: Cardinal Health Inc. – Key news
o Exhibit 125: Cardinal Health Inc. – Key offerings
o Exhibit 126: Cardinal Health Inc. – Segment focus
o 12.7 CODAN Medizinische Gerate GmbH and Co KG
o Exhibit 127: CODAN Medizinische Gerate GmbH and Co KG – Overview
o Exhibit 128: CODAN Medizinische Gerate GmbH and Co KG – Product / Service
o Exhibit 129: CODAN Medizinische Gerate GmbH and Co KG – Key offerings
o 12.8 Eli Lilly and Co.
o Exhibit 130: Eli Lilly and Co. – Overview
o Exhibit 131: Eli Lilly and Co. – Product / Service
o Exhibit 132: Eli Lilly and Co. – Key offerings
o 12.9 Gerresheimer AG
o Exhibit 133: Gerresheimer AG – Overview
o Exhibit 134: Gerresheimer AG – Business segments
o Exhibit 135: Gerresheimer AG – Key news
o Exhibit 136: Gerresheimer AG – Key offerings
o Exhibit 137: Gerresheimer AG – Segment focus
o 12.10 Gulf Pharmaceutical Industries
o Exhibit 138: Gulf Pharmaceutical Industries – Overview
o Exhibit 139: Gulf Pharmaceutical Industries – Product / Service
o Exhibit 140: Gulf Pharmaceutical Industries – Key offerings
o 12.11 Hindustan Syringes and Medical Devices Ltd.
o Exhibit 141: Hindustan Syringes and Medical Devices Ltd. – Overview
o Exhibit 142: Hindustan Syringes and Medical Devices Ltd. – Product / Service
o Exhibit 143: Hindustan Syringes and Medical Devices Ltd. – Key offerings
o 12.12 Mayo Foundation for Medical Education and Research
o Exhibit 144: Mayo Foundation for Medical Education and Research – Overview
o Exhibit 145: Mayo Foundation for Medical Education and Research – Product / Service
o Exhibit 146: Mayo Foundation for Medical Education and Research – Key offerings
o 12.13 Nipro Corp.
o Exhibit 147: Nipro Corp. – Overview
o Exhibit 148: Nipro Corp. – Business segments
o Exhibit 149: Nipro Corp. – Key offerings
o Exhibit 150: Nipro Corp. – Segment focus
o 12.14 Novo Nordisk AS
o Exhibit 151: Novo Nordisk AS – Overview
o Exhibit 152: Novo Nordisk AS – Business segments
o Exhibit 153: Novo Nordisk AS – Key offerings
o Exhibit 154: Novo Nordisk AS – Segment focus
o 12.15 Pfizer Inc.
o Exhibit 155: Pfizer Inc. – Overview
o Exhibit 156: Pfizer Inc. – Product / Service
o Exhibit 157: Pfizer Inc. – Key news
o Exhibit 158: Pfizer Inc. – Key offerings
o 12.16 Sanofi SA
o Exhibit 159: Sanofi SA – Overview
o Exhibit 160: Sanofi SA – Business segments
o Exhibit 161: Sanofi SA – Key news
o Exhibit 162: Sanofi SA – Key offerings
o Exhibit 163: Sanofi SA – Segment focus
o 12.17 Wockhardt Ltd.
o Exhibit 164: Wockhardt Ltd. – Overview
o Exhibit 165: Wockhardt Ltd. – Business segments
o Exhibit 166: Wockhardt Ltd. – Key offerings
o Exhibit 167: Wockhardt Ltd. – Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 168: Inclusions checklist
o Exhibit 169: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 170: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 171: Research methodology
o Exhibit 172: Validation techniques employed for market sizing
o Exhibit 173: Information sources
o 13.5 List of abbreviations
o Exhibit 174: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Type
Exhibits6: Executive Summary – Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on Global insulin market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Type Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Distibution channel Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Type – Market share 2022-2027 (%)
Exhibits31: Data Table on Type – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Insulin analog – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Insulin analog – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Insulin analog – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Insulin analog – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Human insulin – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Human insulin – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Human insulin – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Human insulin – Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Type ($ million)
Exhibits43: Chart on Distribution Channel – Market share 2022-2027 (%)
Exhibits44: Data Table on Distribution Channel – Market share 2022-2027 (%)
Exhibits45: Chart on Comparison by Distribution Channel
Exhibits46: Data Table on Comparison by Distribution Channel
Exhibits47: Chart on Retail pharmacies – Market size and forecast 2022-2027 ($ million)
Exhibits48: Data Table on Retail pharmacies – Market size and forecast 2022-2027 ($ million)
Exhibits49: Chart on Retail pharmacies – Year-over-year growth 2022-2027 (%)
Exhibits50: Data Table on Retail pharmacies – Year-over-year growth 2022-2027 (%)
Exhibits51: Chart on Hospitals – Market size and forecast 2022-2027 ($ million)
Exhibits52: Data Table on Hospitals – Market size and forecast 2022-2027 ($ million)
Exhibits53: Chart on Hospitals – Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Hospitals – Year-over-year growth 2022-2027 (%)
Exhibits55: Chart on Online pharmacies – Market size and forecast 2022-2027 ($ million)
Exhibits56: Data Table on Online pharmacies – Market size and forecast 2022-2027 ($ million)
Exhibits57: Chart on Online pharmacies – Year-over-year growth 2022-2027 (%)
Exhibits58: Data Table on Online pharmacies – Year-over-year growth 2022-2027 (%)
Exhibits59: Market opportunity by Distribution Channel ($ million)
Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits61: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits62: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits63: Chart on Geographic comparison
Exhibits64: Data Table on Geographic comparison
Exhibits65: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits66: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits67: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits68: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits69: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits70: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits71: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits72: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits73: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on Japan – Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on Japan – Year-over-year growth 2022-2027 (%)
Exhibits101: Market opportunity By Geographical Landscape ($ million)
Exhibits102: Impact of drivers and challenges in 2022 and 2027
Exhibits103: Overview on Criticality of inputs and Factors of differentiation
Exhibits104: Overview on factors of disruption
Exhibits105: Impact of key risks on business
Exhibits106: Vendors covered
Exhibits107: Matrix on vendor position and classification
Exhibits108: B. Braun SE – Overview
Exhibits109: B. Braun SE – Business segments
Exhibits110: B. Braun SE – Key news
Exhibits111: B. Braun SE – Key offerings
Exhibits112: B. Braun SE – Segment focus
Exhibits113: Becton Dickinson and Co. – Overview
Exhibits114: Becton Dickinson and Co. – Business segments
Exhibits115: Becton Dickinson and Co. – Key news
Exhibits116: Becton Dickinson and Co. – Key offerings
Exhibits117: Becton Dickinson and Co. – Segment focus
Exhibits118: Biocon Ltd. – Overview
Exhibits119: Biocon Ltd. – Business segments
Exhibits120: Biocon Ltd. – Key offerings
Exhibits121: Biocon Ltd. – Segment focus
Exhibits122: Cardinal Health Inc. – Overview
Exhibits123: Cardinal Health Inc. – Business segments
Exhibits124: Cardinal Health Inc. – Key news
Exhibits125: Cardinal Health Inc. – Key offerings
Exhibits126: Cardinal Health Inc. – Segment focus
Exhibits127: CODAN Medizinische Gerate GmbH and Co KG – Overview
Exhibits128: CODAN Medizinische Gerate GmbH and Co KG – Product / Service
Exhibits129: CODAN Medizinische Gerate GmbH and Co KG – Key offerings
Exhibits130: Eli Lilly and Co. – Overview
Exhibits131: Eli Lilly and Co. – Product / Service
Exhibits132: Eli Lilly and Co. – Key offerings
Exhibits133: Gerresheimer AG – Overview
Exhibits134: Gerresheimer AG – Business segments
Exhibits135: Gerresheimer AG – Key news
Exhibits136: Gerresheimer AG – Key offerings
Exhibits137: Gerresheimer AG – Segment focus
Exhibits138: Gulf Pharmaceutical Industries – Overview
Exhibits139: Gulf Pharmaceutical Industries – Product / Service
Exhibits140: Gulf Pharmaceutical Industries – Key offerings
Exhibits141: Hindustan Syringes and Medical Devices Ltd. – Overview
Exhibits142: Hindustan Syringes and Medical Devices Ltd. – Product / Service
Exhibits143: Hindustan Syringes and Medical Devices Ltd. – Key offerings
Exhibits144: Mayo Foundation for Medical Education and Research – Overview
Exhibits145: Mayo Foundation for Medical Education and Research – Product / Service
Exhibits146: Mayo Foundation for Medical Education and Research – Key offerings
Exhibits147: Nipro Corp. – Overview
Exhibits148: Nipro Corp. – Business segments
Exhibits149: Nipro Corp. – Key offerings
Exhibits150: Nipro Corp. – Segment focus
Exhibits151: Novo Nordisk AS – Overview
Exhibits152: Novo Nordisk AS – Business segments
Exhibits153: Novo Nordisk AS – Key offerings
Exhibits154: Novo Nordisk AS – Segment focus
Exhibits155: Pfizer Inc. – Overview
Exhibits156: Pfizer Inc. – Product / Service
Exhibits157: Pfizer Inc. – Key news
Exhibits158: Pfizer Inc. – Key offerings
Exhibits159: Sanofi SA – Overview
Exhibits160: Sanofi SA – Business segments
Exhibits161: Sanofi SA – Key news
Exhibits162: Sanofi SA – Key offerings
Exhibits163: Sanofi SA – Segment focus
Exhibits164: Wockhardt Ltd. – Overview
Exhibits165: Wockhardt Ltd. – Business segments
Exhibits166: Wockhardt Ltd. – Key offerings
Exhibits167: Wockhardt Ltd. – Segment focus
Exhibits168: Inclusions checklist
Exhibits169: Exclusions checklist
Exhibits170: Currency conversion rates for US$
Exhibits171: Research methodology
Exhibits172: Validation techniques employed for market sizing
Exhibits173: Information sources
Exhibits174: List of abbreviations



★調査レポート[世界のインスリン市場2023年~2027年] (コード:IRTNTR74807-23)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のインスリン市場2023年~2027年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆